InSilicoTrials’ Post

Do you want to know more about #DrugAccess in LATAM from a legal and professional perspective?   Join us at the webinar “DRUG ACCESS” organized by the Global Alliance of Women in Lifesciences (GAWL) to take place next Thursday, August 17, 2023 at 11:00 am (ARG). We will share an interesting discussion on this trending matter from 10 LATAM countries perspective. Please REGISTER at: https://lnkd.in/ex9XJsT7 #lifesciences #drugs #medicines #healthcare #regulatory

The more I look into this, the more I'm shocked by the lack of research in women's health and the lack of consideration and differences between providing proper medication/therapies between sexes. This study, which is one of MANY, begins to shed light on how women report more side effects from certain blood pressure meds than men, even when the dose per kg of body weight is standardized. It's genuinely part of a broader issue: Women's health and responses to medication are heavily under-researched in medicine. Studies like this highlight the critical need for more inclusive research practices, ensuring healthcare is effective and safe for everyone, regardless of gender. I would love to hear from doctors and providers about what their experiences have been in providing medications in this context... #healthtech #innovation #nobodystudios #womenshealth #precisionmedicine

www.elsaydaly.com, an integrated web and its diverse social media platform, is dedicated to disseminating accessible yet scientifically grounded health and wellness information. We prioritize our followers by implementing a diverse range of metrics, including traditional digital marketing measures such as SEO, impressions, engagement, CTR, and potential conversion rates. Emphasizing customer-centricity, we recognize the importance of timely and accurate responses to inquiries as a critical metric. Customer reviews and responses contribute significantly to our ongoing evaluation. Additionally, the expansion of our follower base remains pivotal for maximizing awareness. Other essential metrics include user interactions, content reach, and the impact of educational campaigns on behavioral change. Elsaydaly.com is committed to leveraging a comprehensive set of metrics to continually elevate our standards, ensuring our mission fosters better living through heightened awareness and engagement in the realm of health and wellness. #elsaydaly #elsaydalydotcom #الصيدلي #healthandwellness #healthawareness #womanhealth #geriatrics #teens #pharmaceuticals #betterliving #yourhealthmatters [email protected] [email protected]

One of the major desired outcomes of expanding data gathering and sharing is to promote equal access to clinical trials. Ethnic subgroups are most often underrepresented in clinical trials. If patients in clinical trials do not represent the whole community, there is the risk that differences in drug metabolism, side effect profiles, and outcomes will be missed. Above are ways to mitigate these disparities. #MinorityHealth #SDOH #HealthEquity #healthbenefits #transparency #valuebasedhealthcare

ICER NEWS: The Institute for Clinical and Economic Review (ICER) updated its framework for assessing the cost-effectiveness and value of prescription drugs for the first time since 2020. Among the updates: ICER’s reports will include "Clinical Trial Diversity" and assess trials on race/ethnicity, sex, and age, specifically, adults aged 65 and older. ICER's reports will measure cost-effectiveness results from "both the health care system perspective as well as a modified societal perspective." You can find a list of the major updates to the #ICER framework on page 60, but the whole report is worth reading: https://lnkd.in/g4m_R5QF Don't forget: Read Valuate's POV on how #marketaccess, #pharma and #biotech can leverage ICER report:

We are empowering women worldwide on #InternationalWomensHealthDay! Join us in celebrating women's strength, resilience, and well-being everywhere. Together, let's break barriers, promote health equity, and advocate for women's health rights. To know more about us visit www.jeevanscientific.com #WomenEmpowerment #HealthForAll #medicine #medical #pharmaceuticals #pharma #clinical #clinicaltrials #JSTL #Jeevanscientifictechnologylimited #Jeevanscientific #clinicalresearch

[Age Diversity in Clinical Trials] 有啟發性，值得閱讀的一篇! 👧👨🦰🧓👱♀️ 要收集到多元年齡層參與臨床試驗，同時滿足讓試驗的統計結果顯著，會需要每種藥品case-by-case的去權衡。 也有談到不同年紀對新科技的接受度如何影響往後發展遠程臨床試驗(DCT)。 When clinical trials reflect the population as accurately as possible, data is exponentially more useful, and drug development improves. While we often discuss wider diversity in clinical trials, age diversity has not traditionally received as much attention and medicines are systematically undertested on older adults. #insightful #clinicaltrials #diversity #agediversity

Above and beyond the ethical imperative, diverse clinical trials ensure that potential #medicines or vaccines are safe and effective for everyone. In this article, my colleagues Seema Vadsola, PharmD, MBA and Emanuel Wasson V explain how #pharma can unleash the power of #diversity in clinical trials by building a compelling business case, creating tailored KPIs and fostering a culture of accountability. https://lnkd.in/eKTEhysG #LifeSciences #ClinicalTrials

WEBINAR: See real-world examples of how Medisafe's data helped uncovered meaningful proof points for women's health - and what's being done about it. Save your spot (free): https://lnkd.in/eKuK9Gi9 #Pharma #PatientSupport #WomensHealth

Psilocybin, a psychoactive substance found in certain mushrooms, is gaining popularity in the United States. While some are excited about its potential therapeutic benefits, others are concerned about its impact on healthcare disparities. Recently, its use among wealthy tech executives in Silicon Valley has been a topic of discussion. Stay informed about the ongoing debate surrounding psilocybin decriminalization in the US. Check out the link below for more information. #psilocybin #healthcare #therapy #debate